Global Market for Combination Antibody Therapy Is Set to Ride on a Value CAGR of over 14% During the Period of Assessment to Reach US$ 144,734.5 Million by 2024
global market was valued at over US$ 49,994 Million characterizing the overwhelming popularity of antibody/antibody drugs amongst both practitioners and patients observed in recent years.
View full press release